Celgene Corporation to Present at the 31st Annual J.P. Morgan Healthcare
JPMorgan Healthcare Conference 2013
SUMMIT, N.J. -- December 21, 2012
Celgene Corporation (NASDAQ: CELG) today announced its presentation at the
31^st Annual J.P. Morgan Healthcare Conference on January 7, 2013 at 11:00a.m.
E.T. will be webcast live and will be available in the investor relations
section of the company’s Web site at www.celgene.com. Celgene management will
provide an overview of the company.
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated
global biopharmaceutical company engaged primarily in the discovery,
development and commercialization of novel therapies for the treatment of
cancer and inflammatory diseases through gene and protein regulation. For more
information, please visit the company’s Web site at www.celgene.com.
Jacqualyn A. Fouse, Ph.D, 908-673-9956
EVP, Chief Financial Officer
Patrick E. Flanigan III, 908-673-9969
VP, Investor Relations
Press spacebar to pause and continue. Press esc to stop.